| Ytd | 312.28% | |
| 1y | 347.62% |
| Open | 4.82 | Prev Close | 4.84 | Low | 4.59 | High | 5.01 | Mkt Cap | 169.28M |
| Vol | 112.72K | Avg Vol | 332.36K | EPS | -1.10 | P/E | N/A | Forward P/E | -1.17 |
| Beta | -0.22 | Short Ratio | 0.82 | Inst. Own | 52.31% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-14 | 50-d Avg | 4.58 | 200-d Avg | 2.44 | 1yr Est | 2.67 |
Gainers Pulsenmore (NASDAQ:PLSM) stock increased by 152.0% to $8.59 during Wednesday's pre-mark
AN2 Therapeutics, Inc. (NASDAQ:ANTX) a clinical-stage biopharmaceutical company developing novel sma
Parasite elimination achieved with 28-day treatment in 100% of nonhuman primates (NHPs) naturally in
Leerink Partners analyst Joseph Schwartz upgrades AN2 Therapeutics (NASDAQ:ANTX) from Market Perf
AN2 Therapeutics, Inc. (NASDAQ:ANTX), a clinical-stage biopharmaceutical company developing novel sm
AN2 Therapeutics (NASDAQ:ANTX) reported quarterly losses of $(0.29) per share which missed the analy
AN2 Therapeutics stock dips in premarket after a 90% surge tied to a $40 million equity raise.
AN2 Therapeutics Inc (NASDAQ: ANTX) shares are surging Monday afternoon after the company announced
Substantial clinical evidence provides rationale to initiate Phase 2 study in PVPhase 2 study expect
AN2 aims to advance oral treatment option for patients currently reliant on complex, off-label IV th
AN2 Therapeutics (NASDAQ:ANTX) reported quarterly losses of $(0.31) per share which missed the analy
AN2 awarded third year of funding from Gates FoundationAN2 Therapeutics, Inc. (NASDAQ:ANTX), a bioph
AN2 Therapeutics (NASDAQ:ANTX) reported quarterly losses of $(0.21) per share which beat the analyst
Study highlights high mortality despite standard of care and provides critical data to optimize desi
U.S. stocks traded mostly higher toward the end of trading, while the Nasdaq Composite moved slightl
Shares of Big Lots, Inc. (NYSE: BIG) fell sharply during Monday’s session after the company reporte
U.S. stocks traded higher midway through trading, with the Dow Jones index jumping over 150 points o
U.S. stocks traded mixed this morning, with the Dow Jones index falling around 20 points on Monday.
Friday's session saw 100 companies set new 52-week lows.
On Thursday, 498 companies reached new 52-week lows.
Gainers FedNat Holding Company (NASDAQ: FNHC) shares climbed 107.7% to close at $0.3395 on Tuesda
Gainers
Gainers Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) shares jumped 91.3% to close at $28
Gainers Embark Technology, Inc. (NASDAQ: EMBK) jumped 84.8% to close at $1.07 on Friday after the
Gainers Twin Vee Powercats Co. (NASDAQ: VEEE) shares jumped 90% to $7.60 after the company said Q
On Thursday, 588 stocks hit new 52-week lows.
Gainers Revlon, Inc. (NYSE: REV) jumped 91.3% to close at $3.73 on Friday after the company filed
On Tuesday, 951 companies hit new 52-week lows.
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 154.7% to settle at $12.10 on Tuesday
On Wednesday, 216 stocks hit new 52-week lows.